OT Staff Reports

Articles

Collaboration to focus on biologicals for the treatment of retinal diseases

SemaThera Inc. has announced a research collaboration and licensing agreement with Roche to develop a new class of biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases.

Implementing COVID-19 safety protocols, guidelines in practice

Peter J. Polack, MD, FACS, and Zora Harrison, COO at Ocala Eye, discuss their adaptive approach to the pandemic in implementing health/social distancing guidelines and technology for patients and staff.

Managing pandemic-driven dry eye with nutrition

Peter J. Polack, MD, FACS, of Ocala Eye, discusses how proper patient education and nutrition have been key to managing an increase in dry eye patients during the pandemic.

COVID-19: Year in the life of ophthalmology practice

March 03, 2021

Peter J. Polack, MD, FACS, and Zora Harrison, COO at Ocala Eye, share the protocols and technology their practice implemented throughout the pandemic that has enabled them to safely and efficiently treat their patients.